Hi I’m 76 and I was diagnosed with prostrate cancer in February a PSA of 38 and a Gleason score of 9 I’m currently receiving hormone therapy but today I went as I thought to see about my radio therapy but was asked after a long talk with th consultant if I would consider taking part in the Atlas program which consists of extra medication but is a blind 50-50 program if anyone has any information or experience of this I would be most grateful for any advice.
The Atlas program: Hi I’m 76 and I was... - Advanced Prostate...
The Atlas program
Written by
Webba
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
It is an excellent trial, and your only chance at getting an early shot at getting Erleada (apalutamide), which so far has tested very well. Here are details of the trial:
clinicaltrials.gov/ct2/show...
Even if you don't get randomized to get the apalutamide, you will be no worse off than if you didn't enter the trial. The care and close monitoring you will get by being a trial participant are above and beyond what you would ordinarily get.
As for the radiation part of it, the radiation therapy with the best record of success for GS9s is external beam therapy to the entire pelvis with a brachytherapy boost to the prostate. It is far better than surgery or external beam alone. Here's an article comparing them all:
Not what you're looking for?
You may also like...
Funding Program for Prostate Cancer
drug program and that is $650>$780 a month. I am on social Security I need another funding program...
Abiraterone Zytiga Copay assistance programs HELP
theirs.
I think it would be helpful to list all the manufacturers and their programs. If you are...
Sites for Lu PSMA Early Access Program
treatment in the early access program at UCLA is currently two months long. My PSA will double in...
Custom BAT program
I'm still working on this program and testing it in real-time. Last month my PSA was 0.13, then...
Patient assistance programs help some and hurt many
Patient assistance programs help some patients with co-pay subsidies but hurt all of us by...